Olufunmilayo Olopade to Proto-Oncogene Proteins p21(ras)
This is a "connection" page, showing publications Olufunmilayo Olopade has written about Proto-Oncogene Proteins p21(ras).
Connection Strength
0.219
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol. 2016 05; 141(2):386-401.
Score: 0.122
-
Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clin Cancer Res. 2012 Jan 15; 18(2):350-9.
Score: 0.096